Telephone
61.3.9653.9160
Address
Suite 1 Level 9 432 St Kilda Road Melbourne, Victoria (VIC) 3004
Description
Respiri Ltd. engages in research, development, and commercialization of medical devices and the production of mobile health applications for management of asthma and related chronic respiratory diseases. Its proprietary apps, software, and devices will help people monitor the symptoms of their conditions, increase their awareness of risk of attack, adhere to their medication plans, improve outcomes, and reduce healthcare expenditures. The firm operates through the Australia and Israel segments. The Australia segment includes research, development, and commercialization of medical devices, and the production of mobile health applications in Australia. The Israel segment refers to the research, development and, commercialization of medical devices, and the production of mobile health applications in Israel. The company was founded by Noam Gavriely in 1987 and is headquartered in Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.02 - 0.08
Trade Value (12mth)
AU$4,790.00
1 week
0%
1 month
19.23%
YTD
-32.61%
1 year
-13.89%
All time high
6.57474
EPS 3 yr Growth
-43.300%
EBITDA Margin
%
Operating Cashflow
-$4m
Free Cash Flow Return
-227.30%
ROIC
-292.30%
Interest Coverage
-418.30
Quick Ratio
0.80
Shares on Issue (Fully Dilluted)
829m
HALO Sector
Healthcare
Next Company Report Date
29-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
31 October 13 |
Isonea Limited - Results of 2013 Annual General Meeting (ISN-AU)
×
Isonea Limited - Results of 2013 Annual General Meeting (ISN-AU) |
31 May 23 |
Change of Director's Interest Notice BL
×
Change of Director's Interest Notice BL |
31 May 23 |
Change of Director's Interest Notice (correction) BL
×
Change of Director's Interest Notice (correction) BL |
31 August 23 |
Preliminary Final Report
×
Preliminary Final Report |
31 August 23 |
2023 Corporate Governance Statement and App4G
×
2023 Corporate Governance Statement and App4G |
31 August 22 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
31 August 22 |
Preliminary Final Report
×
Preliminary Final Report |
31 August 22 |
Annual Report to shareholders
×
Annual Report to shareholders |
31 August 16 |
Appendix 4E & Annual Financial Report (30 June 2016)
×
Appendix 4E & Annual Financial Report (30 June 2016) |
30 September 22 |
Respiri commences trading on the OTCQB
×
Respiri commences trading on the OTCQB |
30 September 13 |
Isonea Limited - 2013 Annual Report to Shareholders (ISN-AU)
×
Isonea Limited - 2013 Annual Report to Shareholders (ISN-AU) |
30 September 10 |
2010 Annual Report (KSX-AU)
×
2010 Annual Report (KSX-AU) |
30 September 09 |
Annual Report to shareholders (KSX-AU)
×
Annual Report to shareholders (KSX-AU) |
30 November 10 |
KarmelSonix AGM Presentation (KSX-AU)
×
KarmelSonix AGM Presentation (KSX-AU) |
30 November 10 |
Results of Annual General Meeting (KSX-AU)
×
Results of Annual General Meeting (KSX-AU) |
30 June 23 |
Prospectus - Share Purchase Plan Offer
×
Prospectus - Share Purchase Plan Offer |
30 June 23 |
Share Purchase Plan offer invitation letter
×
Share Purchase Plan offer invitation letter |
30 June 23 |
Update - Proposed issue of securities - RSH
×
Update - Proposed issue of securities - RSH |
30 June 23 |
Update - Proposed issue of securities - RSH
×
Update - Proposed issue of securities - RSH |
30 December 22 |
Disclosure Document S708 cleansing notice for SPP
×
Disclosure Document S708 cleansing notice for SPP |
30 December 22 |
Security Purchase Plan - Offer Booklet
×
Security Purchase Plan - Offer Booklet |
30 August 23 |
Investor update - delivering RPM solutions to US health mkt
×
Investor update - delivering RPM solutions to US health mkt |
30 August 17 |
Appendix 4E & Annual Financial Report (30 June 2017)
×
Appendix 4E & Annual Financial Report (30 June 2017) |
29 September 23 |
Further USA Customer Base Growth - ShareCafe Presention
×
Further USA Customer Base Growth - ShareCafe Presention |
29 September 23 |
Application for quotation of securities - RSH
×
Application for quotation of securities - RSH |
29 September 22 |
Update - Proposed issue of securities - RSH
×
Update - Proposed issue of securities - RSH |
29 September 20 |
Annual Report to shareholders
×
Annual Report to shareholders |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.